FZD8 and Cowden disease: Furthermore, we identify small-molecule inhibitors of FZD8 (3235-0367 (C1)), Porcupine (Wnt-C59), and β-catenin (ICG-001) as potential novel therapies for intestinal fibrosis in CD.